OccuLogix, Inc. dba TearLab Corporation (TearLab) announced the departure of Eric Donsky as its chief executive officer (CEO), effective June 29, 2009, to pursue other opportunities. In addition, the company has appointed its chairman, Elias Vamvakas, to serve as interim CEO until a permanent replacement for Donsky can be found.

On behalf of the Board, I would like to take this opportunity to thank Eric for his dedication and many valuable contributions. Eric founded OcuSense with Dr. Benjamin Sullivan in 2003 and remained CEO through its merger with Occulogix in October 2008.” commented company director, Donald Rindell.

Having previously served as CEO of Occulogix from July 2004 until October 2008, we are confident that Elias will provide the Company with both excellent leadership and important continuity as it works to bring the Tearlab Osmolarity System successfully to market, continued Rindell.

TearLab is an in-vitro diagnostics company that develops and commercializes a proprietary tear testing platform, TearLab, for use in the physician and clinical office.